Skip to main content

461 Pill: beige, oval, 10mm

The pill with imprint 461 (Beige, Oval, 10mm) has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg and is used for Parkinson's Disease, Neuroleptic Malignant Syndrome, and GTP-CH Deficiency. It belongs to the drug class dopaminergic antiparkinsonism agents and is not a controlled substance.

Images for 461

Carbidopa and levodopa extended release 25 mg / 100 mg 461 Front
Carbidopa and levodopa extended release 25 mg / 100 mg 461 Back
Carbidopa and levodopa extended release 25 mg / 100 mg 461

Carbidopa and Levodopa Extended Release

Imprint
461
Strength
25 mg / 100 mg
Color
Beige
Size
10.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Caraco Pharmaceutical Laboratories
National Drug Code (NDC)
62756-0461
Inactive Ingredients
microcrystalline cellulose, silicon dioxide, hydroxypropyl cellulose (type l), ferric oxide red, D&C Yellow No. 10, hypromelloses, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "461"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.